Lexaria Bioscience LEXX
NASDAQ LEXX
$2.51 -0.31 (-10.45%)
As of: Oct 22, 2026 · 10:09 AM EDT

Lexaria Bioscience (LEXX) Long-Term Debt Issuances (2011 - 2020)

Updated

Lexaria Bioscience's Long-Term Debt Issuances came in at $1,914 for fiscal Q4 2020 (quarter ended Aug 31, 2020).

Analysis

Lexaria Bioscience (LEXX) Long-Term Debt Issuances (2011 - 2020) Analysis & Trends

For FY2020 (ended Aug 31, 2020), Lexaria Bioscience's Long-Term Debt Issuances was $30,670.

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of -42.1% (FY2015 to FY2020).
  • The fiscal Q4 2020 figure represents the highest quarterly Long-Term Debt Issuances since fiscal Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,164.71 Bn 1,133.30 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 633.37 Bn 551.90 Bn 17.26 Bn -
3 AbbVie 503.99 Bn 477.10 Bn 12.70 Bn -
4 Merck 378.19 Bn 332.57 Bn 12.21 Bn -
5 Novartis Ag 303.15 Bn 267.14 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 266.17 Bn 239.85 Bn 12.86 Bn -
7 Amgen 241.38 Bn 196.78 Bn 7.24 Bn -
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn -
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -
10 Lexaria Bioscience 2.32 Mn -12.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2020 1,914.00
May 31, 2016 -41,980.00
Feb 29, 2016 50,980.00
Nov 30, 2015 36,000.00
Aug 31, 2015 4,897.00
May 31, 2015 467,100.00
Apr 30, 2014 1.28 Mn
Jan 31, 2014 30,000.00
Jan 31, 2012 200,000.00
Oct 31, 2011 -33,092.00
Jul 31, 2011 70,000.00
API Access

Lexaria Bioscience Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=LEXX&period=max&api_key=YOUR_API_KEY